Analyst Ratings for Cara Therapeutics (CARA)

CARA Rating Summary

  |   Expand Research on CARA
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 52%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/13/2024 H.C. Wainwright Oren Livnat Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.68
(5.32)		 682.35% Details
6/13/2024 Needham Joseph Stringer Downgrade Hold
(Buy)		 N/A
(N/A)		 0.68
(5.32)		 682.35% Details